Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
939
-
Total shares
-
40.8M
-
Shares change
-
-2.33M
-
Total reported value, excl. options
-
$6.22B
-
Value change
-
-$361M
-
Put/Call ratio
-
0.92
-
Number of buys
-
385
-
Number of sells
-
-312
-
Price
-
$152.62
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2021
976 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2021.
ISHARES TR - ISHARES BIOTECH (IBB) has 939 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.8M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (11.7M shares), MORGAN STANLEY (3.8M shares), UBS Group AG (1.86M shares), CITIGROUP INC (1.6M shares), ROYAL BANK OF CANADA (1.34M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (1.31M shares), BNP PARIBAS ARBITRAGE, SA (1.28M shares), GOLDMAN SACHS GROUP INC (1.17M shares), COMMERCE BANK (584K shares), and LPL Financial LLC (541K shares).
This table shows the top 939 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.